Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. - Wikidata - awgldk - TriplyDB

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

http://www.wikidata.org/entity/Q37620387

about

Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy Cachexia and pancreatic cancer: are there treatment options?Enobosarm (GTx-024, S-22): a potential treatment for cachexia.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Molecular and cellular mechanisms of skeletal muscle atrophy: an update.Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes.Computer-aided (in silico) approaches in the mode-of-action analysis and safety assessment of ostarine and 4-methylamphetamine.Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.

P2860

Q27026488-8602FFEC-6489-4EC2-8A31-78D30AA3DFB4 Q27026558-E5A956A5-6D8F-4FA0-B2C2-879A3135EF10 Q34401825-B0A8BE90-5333-406D-993E-C1F460868B61 Q35122201-5C355B1C-C665-463A-B984-BD402F394B61 Q36179105-22A9ADD4-DD98-4E1F-9360-81E5D72AA404 Q38691193-88953CCA-57FD-4D56-88CC-8250A9C9BE9B Q39379084-EB857110-F32F-42DE-BC3C-896479BB396D Q39734819-5B9189E5-567E-42FA-A660-6CD76D35B6F7

P2860

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

http://www.wikidata.org/entity/Q37620387

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@en

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@nl

type

label

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@en

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@nl

prefLabel

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@en

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

@nl

P1433

Q37620387-A39CE3E0-ADC5-44A0-A936-73903A23A9B1

P1476

Q37620387-C89E3EF6-71A2-4156-BCC6-A3668929927A

P2093

Q37620387-9BC5D70F-3206-470F-AEAD-114E7B965C0C

P2860

Q37620387-1AA6A169-1217-46E4-A717-66CF102B71F1

Q37620387-22E90400-665F-4814-973A-C22D2620116D

Q37620387-25BCCA4E-95A1-4053-84A0-831833F8CD61

Q37620387-2733FEC5-9771-49B0-9D26-A3FC1FBEB6BE

Q37620387-2F48A58F-996B-423E-8D39-E93B9609A4D2

Q37620387-31D73080-33CC-4654-A7A7-E9F6875D42A3

Q37620387-3242398D-F7FA-4825-AEF9-12149C5E0E67

Q37620387-3CA16512-033B-47E5-A697-443E079385EC

Q37620387-3D6EA8ED-BAB4-421A-A4C0-472AE44F4287

Q37620387-3DBE26F8-756F-4F87-83CC-170CB66718A4

P304

Q37620387-896E1328-6974-41EE-92A1-2768C60E17AF

P31

Q37620387-3A4A3F01-1481-4EDC-A579-6EF11BA4F6CF

P356

Q37620387-53E17515-ADBE-419E-9C3F-6364FF8FC516

P407

Q37620387-FF872A2C-4DAE-4FC1-B847-87700112E105

P433

Q37620387-CE3ABD73-D0FE-4C2F-B755-6DEAAE7E98FB

P478

Q37620387-BAB2C9AC-45B2-490D-8490-E367BED79DDB

P50

Q37620387-05882172-E100-4EDD-90B0-55D2E00D5B64

P577

Q37620387-3DBCE1A8-D7F0-4BAA-BB66-FAD2D2A7BDF8

P698

Q37620387-BCBDD61F-DF8F-4B93-8520-B54C94ECB4DD

P356

P1433

Future Oncology

P1476

Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia

@en

P2093

Adrian S Dobs

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats

Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)

Discovery and therapeutic promise of selective androgen receptor modulators

Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands

Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

P304

1211-1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.106

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mihail Zilbermint

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19852734

http://www.w3.org/2001/XMLSchema#string